TORC1/2 INHIBITOR INK128 AND EGFR INHIBITOR AZD9291 IN TREATING PATIENTS WITH ADVANCED EGFR MUTATION POSITIVE NON-SMALL CELL LUNG CANCER AFTER PROGRESSION ON A PREVIOUS EGFR TYROSINE KINASE INHIBITOR: